Source: FierceBiotech

TVA Medical: FDA clears catheter-based hemodialysis vascular access systems

The FDA has cleared catheter-based vascular access systems for sale. Both devices enable physicians to create arteriovenous (AV) fistulas through the skin, thereby simplifying a vital preparatory step for hemodialysis patients.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more